logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
arrow
S

Stanley Lipkowitz

National Cancer Institute
H指数:41
被引数:8,399

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Small molecule activators of the mitochondrial protease ClpP induce senescence in triple-negative breast cancer cells and sensitize cells to the Bcl-2 inhibitor venetoclax

小分子线粒体蛋白酶ClpP的激活剂在三阴性乳腺癌细胞中诱导衰老并使细胞对Bcl-2抑制剂venetoclax更敏感

Cell Death & Disease
IF9.6
2026-06-290
OAAI
Sabrina C. D. Daglish; Owen G. Canterbury; Paul R. Graves; Sarah A. Carter; Sydney M. Beese; Brandon L. Mouery; Maggie A. Hynek; Elizabeth C. Moorman; Andrei J. Mistreanu; Aadra P. Bhatt; Nestor Tellez; Mitchell T. Butler; Lucas J. Aponte-Collazo; Emily M. J. Fennell; Laura E. Herring; Scott Lyons; C. Allie Mills; Hani Ashamalla; Edwin J. Iwanowicz; John P. Morris IV; James E. Bear; Yoshimi Endo Greer; Stanley Lipkowitz; Lee M. Graves
Durvalumab and cediranib with and without olaparib in recurrent ovarian cancer: a phase II proof-of-concept study

Durvalumab和cediranib联合或不联合olaparib治疗复发性卵巢癌：一项II期概念验证研究

Nature Communications
IF15.7
2026-03-160
OAAI
Junya Tabata; Tzu-Ting Huang; Elena Giudice; Kristen R. Ibanez; Jayakumar R. Nair; Aanika Balaji Warner; Britanny B. Solarz; Valentina Bolanos; Bernadette Redd; Nahoko Sato; Shraddha Rastogi; Sunmin Lee; Roshan L. Shrestha; Alexander Y. Mitrophanov; Stanley Lipkowitz; Kevin Conlon; Chien Chu Huang; Jung-Min Lee
Trastuzumab deruxtecan efficacy, FcRn-facilitated penetration of the blood-tumor barrier, and distribution to tumor cells in HER2+brain metastasis model systems

曲妥珠单抗德鲁替康的疗效、FcRn介导的血-肿瘤屏障穿透以及向HER2阳性脑转移模型系统中肿瘤细胞的分布

Neuro-Oncology
IF13.4
2026-02-010
PRE
Khan, Imran; Kumar, Dinesh; Zhang, Wei; Difilippantonio, Simone; Robinson, Christina; Wei, Debbie; Lipkowitz, Stanley; Lake, Ross; Fleming, Ronald; Steeg, Patricia S.
A Phase II Pilot Study of Anti-PD-L1, Durvalumab, and a PARP Inhibitor, Olaparib in Patients With Metastatic Triple-Negative Breast Cancer With or Without Germline BRCA Mutation

一项关于抗PD-L1药物Durvalumab和PARP抑制剂Olaparib在携带或不携带胚系BRCA突变的转移性三阴性乳腺癌患者中的II期探索性研究

CANCER MEDICINE
IF3.1
2025-12-080
OAAI
Fujii, Takeo; Cimino-mathews, Ashley; Lipkowitz, Stanley; Lee, Min-Jung; Nair, Jayakumar; Solarz, Britanny Brooke; Zimmer, Alexandra; Redd, Bernadette; Levy, Elliot B.; Rastogi, Shraddha; Sato, Nahoko; McCoy, Ann; Steinberg, Seth M.; Lee, Jung-Min
A CSF-1R inhibitor both prevents and treats triple-negative breast cancer brain metastases in hematogenous preclinical models

一种CSF-1R抑制剂在血液传播的预临床模型中既可预防又可治疗三阴性乳腺癌脑转移瘤

Clinical & Experimental Metastasis
IF3.2
2025-08-040
OAAI
Wei Zhang; Samiur Rahman; Alex M. L. Wu; Kristine Isanogle; Christina Robinson; Dinesh Kumar; Imran Khan; Debbie Wei; Alexandra S. Zimmer; Takeo Fujii; Simone Difilippantonio; Stanley Lipkowitz; Patricia Steeg
TRAIL induces cytokine production via the NFkB2 pathway promoting neutrophil chemotaxis and neutrophil-mediated immune-suppression in triple negative breast cancer cells

TRAIL通过NFkB2通路诱导细胞因子产生，促进中性粒细胞趋化作用以及三阴性乳腺癌细胞中的中性粒细胞介导的免疫抑制。

CANCER LETTERS
IF10.1
2025-06-010
PRE
Kundu, Manjari; Greer, Yoshimi E.; Lobanov, Alexei; Ridnour, Lisa; Donahue, Renee N.; Ng, Yeap; Ratnayake, Shashi; White, Karley; Voeller, Donna; Weltz, Sarah; Chen, Qingrong; Lockett, Stephen J.; Cam, Maggie; Meerzaman, Daoud; Wink, David A.; Weigert, Roberto; Lipkowitz, Stanley
Targeting metabolic vulnerability by combining NAMPT inhibitors and disulfiram for treatment of recurrent ovarian cancer

通过联合应用NAMPT抑制剂和disulfiram靶向代谢脆弱性以治疗复发性卵巢癌

CELL DEATH & DISEASE
IF9.6
2025-04-250
OA
Kudo, Kei; Greer, Yoshimi Endo; Crooks, Daniel R.; Yang, Ye; Brender, Jeffrey R.; Yoshida, Teruhiko; Harrington, Brittney S.; Kamdar, Rahul; Korrapati, Soumya; Shibuya, Yusuke; Henegar, Leah; Kopp, Jeffrey; Fujii, Takeo; Lipkowitz, Stanley; Annunziata, Christina M.
First-in-human phase 1 clinical trial of anti-core 1 O-glycans targeting monoclonal antibody NEO-201 in treatment-refractory solid tumors (vol 42, 76, 2023)
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
IF12.8
2023-04-262
OAAI
Cole, Christopher B.; Morelli, Maria Pia; Fantini, Massimo; Miettinen, Markku; Fetsch, Patricia; Peer, Cody; Figg, William D.; Yin, Tyler; Houston, Nicole; McCoy, Ann; Lipkowitz, Stanley; Zimmer, Alexandra; Lee, Jung-min; Pavelova, Miroslava; Villanueva, Erin N.; Trewhitt, Kathryn; Solarz, B. Brooke; Fergusson, Maria; Mavroukakis, Sharon A.; Zaki, Anjum; Tsang, Kwong Y.; Arlen, Philip M.; Annunziata, Christina M.

研究方向

暂未获取到该数据
Y
Yoshimi Endo Greer
H 指数:18论文数:78被引数:964
D
Donna Voeller
H 指数:24论文数:120被引数:1,909
A
Alexandra S. Zimmer
H 指数:16论文数:90被引数:1,669
C
Christina M. Annunziata
H 指数:45论文数:396被引数:8,682
M
Marion M. Nau
H 指数:47论文数:110被引数:1.1万
P
Patricia S. Steeg
H 指数:86论文数:591被引数:3.2万
S
Seth M. Steinberg
H 指数:148论文数:1,645被引数:8.7万
P
Philip Ryan
H 指数:16论文数:45被引数:1,088
S
Stephen C. Kales
H 指数:22论文数:81被引数:2,065
T
Takeo Fujii
H 指数:24论文数:133被引数:2,327